white paper

Lights on for Autism: Exploring Photobiomodulation as an Effective Therapeutic Option

Abstract
Autism is a neurodevelopmental condition that starts in childhood and continues into adulthood. The core characteristics include difficulties with social interaction and communication, together with restricted and repetitive behaviours. There are a number of key abnormalities of brain structure and function that trigger these behavioural patterns, including an imbalance of functional connectivity and synaptic transmission, neuronal death, gliosis and inflammation. In addition, autism has been linked to alterations in the gut microbiome. Unfortunately, as it stands, there are few treatment options available for patients. In this mini-review, we consider the effectiveness of a potential new treatment for autism, known as photobiomodulation, the therapeutic use of red to near infrared light on body tissues. This treatment has been shown in a range of pathological conditions-to improve the key changes that characterise autism, including the functional connectivity and survival patterns of neurones, the patterns of gliosis and inflammation and the composition of the microbiome. We highlight the idea that photobiomodulation may form an ideal treatment option for autism, one that is certainly worthy of further investigation.

Read more on mdpi.com or download the PDF

Preclinical Studies of Transcranial Photobiomodulation in the Neurological Diseases

Photobiomodulation (PBM) takes advantage of red and near-infrared light to induce therapeutic effects on various kinds of diseases, with transcranial PBM (tPBM) attracting most attention on neurological diseases. Displaying a noninvasive superiority over traditional treatment, tPBM is increasingly studied among research groups. Growing numbers of studies have been conducted in the last decade regarding neurological diseases; however, the research objects and lighting parameters among these papers varied from each other. This article introduces the biophotonics nature of PBM, records the experimental parameters of preclinical studies since 2014 and summarizes the application of tPBM on the neurobiological diseases in the past two decades. Under the summarized guidance of parameter setup, tPBM will be shining light in the prevention and treatment of neurological diseases.

 

Read more on Translational Biophotonics or download the PDF»

ECAM2021-6693916.008

Effect of Near-Infrared Pulsed Light on the Human Brain Using Electroencephalography

In our previous study, the low-level laser (LLL) stimulation at the palm with a stimulation frequency of 10 Hz was able to induce significant brain activation in normal subjects. The electroencephalography (EEG) changes caused by the stimulation of light-emitting diode (LED) in normal subjects have not been investigated. This study aimed at identifying the effects of LED stimulation on the human brain using EEG analysis. Moreover, the dosage has been raised 4 times than that in the previous LLL study. The LED array stimulator (6 pcs LEDs, central wavelength 850 nm, output power 30 mW, and operating frequency 10 Hz) was used as the stimulation source. The LED stimulation was found to induce significant variation in alpha activity in the occipital, parietal, and temporal regions of the brain. Compared to the previous low-level laser study, LED has similar effects on EEG in alpha (8-12 Hz) activity. Theta (4-7 Hz) power significantly increased in the posterior head region of the brain. The effect lasted for at least 15 minutes after stimulation ceased. Conversely, beta (13-35 Hz) intensity in the right parietal area increased significantly, and a biphasic dose response has been observed in this study.

 

Read more on National Institutes of Health or download the PDF »

white paper

Experts review progress in using photobiomodulation therapy to treat diverse brain disorders

By Emily Henderson, B.Sc. |Newsmedical.com | October 14, 2021

Photobiomodulation (PBM) offers exciting opportunities for improving the life of patients with a diverse range of brain disorders. In this special collection of articles in the Journal of Alzheimer’s Disease experts review progress using PBM therapy to treat dementia, Alzheimer’s disease, Parkinson’s disease, and other disorders and suggest larger clinical trials should be conducted as soon as possible.

READ ONLINE»  |  DOWNLOAD PDF»

white paper

Transcranial photobiomodulation with 1064-nm laser modulates brain electroencephalogram rhythms

Abstract

Noninvasive transcranial photobiomodulation (tPBM) with a 1064-nm laser has been reported to improve human performance on cognitive tasks as well as locally upregulate cerebral oxygen metabolism and hemodynamics. However, it is unknown whether 1064-nm tPBM also modulates electrophysiology, and specifically neural oscillations, in the human brain. The hypothesis guiding our study is that applying 1064-nm tPBM of the right prefrontal cortex enhances neurophysiological rhythms at specific frequency bands in the human brain under resting conditions. To test this hypothesis, we recorded the 64-channel scalp electroencephalogram (EEG) before, during, and after the application of 11 min of 4-cm-diameter tPBM (CW 1064-nm laser with 162  mW  /  cm2 and 107  J  /  cm2) to the right forehead of human subjects (n  =  20) using a within-subject, sham-controlled design. Time-resolved scalp topographies of EEG power at five frequency bands were computed to examine the tPBM-induced EEG power changes across the scalp. The results show time-dependent, significant increases of EEG spectral powers at the alpha (8 to 13 Hz) and beta (13 to 30 Hz) bands at broad scalp regions, exhibiting a front-to-back pattern. The findings provide the first sham-controlled topographic mapping that tPBM increases the strength of electrophysiological oscillations (alpha and beta bands) while also shedding light on the mechanisms of tPBM in the human brain.

Neurophotonics, Vol. 6, Issue 2,

READ MORE» | DOWNLOAD PDF»

Effects of Home Photobiomodulation Treatments on Cognitive & Behavioral Function, Cerebral Perfusion and Resting-State Functional Connectivity in Patients with Dementia

This study sought to replicate and build upon a previously published cases series report describing improved cognitive function in five patients with mild to moderate dementia after 12 weeks of transcranial and intranasal near-infrared (NIR) PBM therapy.

In collaboration with the University of California San Francisco using the Neuro Gamma device on neural connectivity and cerebral blood flow.

READ MORE

Pulsed Near Infrared Transcranial and Intranasal Photobiomodulation Significantly Modulates Neural Oscillations

Transcranial PBM (tPBM), targeting delivery of light energy to the brain, is associated with increased cerebral blood flow, oxygen availability and consumption, adenoside triphophosphate (ATP) production, and improved mitochondrial activity4. More recently, tPBM has demonstrated its value as a treatment for neurological5–10 and neurodegenerative conditions, including Alzheimer’s disease11,12. Thus, tPBM is a form of non-invasive brain stimulation (NIBS). However, compared to the more established forms of NIBS, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), the concept of the brain being responsive to light stimulation is unfamiliar to many. In recent years, research on the potential efficacy of tPBM has gained momentum13. Research on the effect of PBM on brain cell recovery has shown that, under laboratory conditions, damaged neurons can regrow their neurites with direct exposure to visible red low level lasers14. In an animal study, PBM has been found capable of promoting neurogenesis after ischemic stroke through the proliferation and differentiation of internal neuroprogenitor cells.

Nature

READ MORE